| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 3e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |